hamburger-icon
close-icon

invest-iconInvest

trade-iconTrade

depository-iconTrading Platforms

depository-iconDepository

watch-iconWatch Markets

depository-iconFPI

watch-iconMerchant Banking

watch-iconInstitutional Broking

watch-iconPMS

watch-iconPre-IPO

watch-iconStock Market Institute – AIFE

watch-iconMTF

partner-iconBecome a Partner

partner-iconKnowledge Center

watch-iconResearch

support-iconWealth Basket

about-iconAbout Us

support-iconSupport

support-iconPricing

support-iconQuick Links

support-iconBlog

support-iconAlgo Trading

hamburger-icon
close-icon

Solara Active Pharma Sciences Ltd Partly Paidup

  • BSE Code : 890202
  • NSE Symbol : SOLARAPP1
  • ISIN : IN9624Z01022
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN
Trade Now

up-arrow 302.00 0.00(0.00%)

Open Price (₹)

282.00

Prev. Close (₹)

302.00

Volume (No’s)

3,446

Market Cap (₹)

362.36

Low Price (₹)

282.00

High Price (₹)

310.00

 

Book Closure

From Date To Date Announcement
02-Apr-2026 NA Second & Final call of Rs.112.50/-per equity shares
02-Apr-2026 NA Trading Members of the Exchange are hereby informed that, SOLARA ACTIVE PHARMA SCIENCES LIMITED has fixed the Record Date for the purpose of determining the holders of partly paid-up Equity Shares to whom the call notice will be dispatched for payment of the Second and Final Call. Hence, Trading Members are advised not to deal in the Partly Paid Equity Shares of the Company as menOoned under:- COMPANY NAME CODE SOLARA ACTIVE PHARMA SCIENCES LIMITED Partly Paid up Equity Shares (890202) RECORD DATE 02/04/2026 PURPOSE To ascertain the Shareholders of Partly Paid Equity Shares who are eligible to pay the Second and Final call of Rs. 112.50 per Equity Share (Rs. 3.00/- towards Face Value and Rs.109.50 towards SecuriOes Premium) towards Partly Paid Shares of the Company NO DEALINGS FROM DATE & SETT. NO 02/04/2026 DR-603/2026-2027
02-Apr-2026 NA Sub: Suspension of partly paid-up equity shares of Solara Active Pharma Sciences Limited In pursuance of Regulation 3.1.2 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the following security will be suspended from trading w.e.f. April 02, 2026 (i.e., closing hours of trading on April 01, 2026). Name of the Company Solara Active Pharma Sciences Limited Symbol SOLARAPP1 ISIN IN9624Z01022 Reason for Suspension Suspension on account of second & final call This Circular shall be effective from April 02, 2026. For and on behalf of National Stock Exchange of India Limited
24-Mar-2026 NA In continuation to the Exchange Notice No. 20260129-13 dated 29th January, 2026, Trading Members of the Exchange are hereby informed that further 71402 Partly Paid Equity Shares of Solara Active Pharma Sciences Limited (Scrip Code 890202) shall be listed and permitted to trade on the Exchange with eUect from Tuesday, 24th March, 2026 as per details given below Company Name & Scrip Code Partly Paid up Equity Shares (890202) New ISIN No. IN9624Z01022 Market Lot 1 Remarks 71402 Equity Shares of the Face Value of Rs.10/- each issued on Rights basis and Partly Paid upto Rs.7/- per Share (First Call Money received of Rs.131.25 per Share out of which Rs.3.50 to be adjusted towards Face Value and Rs.127.75 towards Premium) Synopsis containing details of partly paid shares available for Trading w.e.f. 24th March, 2026 is a?ached herewith.
24-Mar-2026 NA Sub: Listing of Partly Paid-up Equity Shares of Solara Active Pharma Sciences Limited In pursuance of Regulation 3.1.1 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the list of securities further admitted to dealings on the National Stock Exchange (Capital Market segment) with effect from March 24, 2026, and the designated security codes thereof shall be as specified in Annexure. In pursuance of Regulation 2.5.5 of the National Stock Exchange (Capital Market) Trading Regulations Part A, it is hereby notified that the respective lot sizes in respect of securities above shall be as specified in Annexure. For the purpose of trading on the system, security shall be identified only by its designated codes and trading in such securities shall be in such lot sizes as specified in Annexure. This circular shall be effective from March 24, 2026. For and on behalf of National Stock Exchange of India Limited Symbol SOLARAPP1 Company Name Solara Active Pharma Sciences Limited Security description Equity Shares of Rs. 10/- each (Rs. 7/- Paid up) ISIN Code IN9624Z01022 No. of Securities 71,402 Market Lot 1 Lock-in shares Nil Total Distinctive Numbers From To Shares 47766814 47838215 71,402 Total 71,402 *Currently equity shares allotted in dematerialized mode have been credited under the temporary ISIN (IN8624Z01031) in accordance with the SEBI circular no. CIR/MRD/DP/21/2012 dated August 02, 2012, and CIR/MRD/DP/24/2012 dated September 11, 2012, regarding activation of ISIN in case of additional issue of shares / securities.

NIFTY:22,713.10  Up arrow
33.70(0.15%)
SENSEX:73,134.32  Up arrow
185.23(0.25%)

Product

Trading


Useful links

Who we are

Connect with us

Stay on top of the markets with our bite-sized newsletter delivered right to your Inbox!

footer-arrow-icon
appstore appstore

#1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093.

Arihant Capital Markets Limited is a SEBI registered stock broker and depository participant. SEBI Registration number: INZ000180939, Member of NSE:07839; BSE :313; NSDL - IN-DP-127-2015 DP ID-IN301983; CDSL DP ID-43000; NCDEX - 01274; MCX - 56565; AMFI - ARN 15114; AMFI-registered Mutual Fund Distributor; ARN registration year - 2004; ARN validity up to- 18/12/2028; SEBI Merchant Banking Reg. No. - MB INM000011070; SEBI Research Analyst Reg. No. - INH000002764 (BSE RA Enlistment No. 5168) . Registered Address: 601, Atlantis Tower, Plot No. 13 A, Scheme N0. 78, Indore 452010 (MP). Corporate office address: #1011 Solitaire Corporate Park, Andheri Ghatkopar Link Road, Chakala, Andheri (E), Mumbai - 400093. CIN: L66120MP1992PLC007182.

APMI Distributor Registration Name of Distributor : Arihant Capital Markets limited Enrollment Date : 26/03/2025 APRN Code : APRN04950 APRN code is valid from 06/01/2025 till 05/01/2028.

Please carefully read the risk disclosure document as prescribed by SEBI, as well as the 'Do’s and Don’ts' provided by NSE, BSE, NCDEX, and MCX. If you have any complaints related to securities broking, kindly contact us at complaint@arihantcapital.com. For DP-related matters, please reach out to us at depository@arihantcapital.com.

If you want to register your complaints through SEBI Score 2.0 Portal please click here. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances

Investments in securities market are subject to market risks; read all the related documents carefully before investing.

Disclaimer: Arihant Capital Markets Limited is engaged in client based and proprietary trading on various exchanges.

  • ATTENTION INVESTORS :
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • For Stock Broking Transaction 'Prevent unauthorised transactions in your account - update your mobile numbers/email IDs with your stockbrokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.
  • For Depository Transaction 'Prevent Unauthorized Transactions in your demat account - Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL/NSDL on the same day.
  • If you are subscribing to an IPO, there is no need to issue cheques. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website.
  • Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
  • Pay 20% or "var + elm" whichever is higher as upfront margin of the transaction value to trade in cash market segment.
  • Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

  • Risk disclosures on Derivatives:
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost

  • Advisory - Investors :
  • Ensure that pay-out of funds/securities is received in your account within 1 working day from the date of pay-out.
  • Register for online applications viz Speed-e and Easiest provided by Depositories for online delivery of securities as an alternative to DDPI/POA.
  • Ensure that you receive Contract Notes within 24 hours of your trades and Statement of Account at least once in a quarter from your Stock Broker.
  • If you have opted for running account, please ensure that the stock broker settles your account regularly and in any case not later than 90 days (or 30 days if you have opted for 30 days settlement).
  • Do not keep funds idle with the Stock Broker.
  • Regularly login into your account to verify balances and verify the demat statement received from depositories for correctness.
  • Check messages sent by Exchanges on a monthly basis regarding funds and securities balances reported by the trading member and immediately raise a concern if you notice a discrepancy.
  • Always keep your contact details viz Mobile number / Email ID updated with the stock broker. You may take up the matter with Stock Broker / Exchange if you are not receiving the messages from Exchange / Depositories regularly.
  • If you observe any discrepancies in your account or settlements, immediately take up the same with your stock broker and if the Stock Broker does not respond, with the Exchange/Depositories.
  • Beware of fixed/guaranteed/regular returns/ capital protection schemes. Brokers or their authorized persons or any of their associates are not authorized to offer fixed/guaranteed/regular returns/ capital protection on your investment or authorized to enter into any loan agreement with you to pay interest on the funds offered by you. Please note that in case of default of a member claim for funds or securities given to the broker under any arrangement/ agreement of indicative return will not be accepted by the relevant Committee of the Exchange as per the approved norms.
  • Please do not transfer funds, for the purposes of trading to anyone, including an authorized person or an associate of the broker, other than a SEBI registered Stock broker.

  • As per advisory issued by exchanges, while dealing in options, clients/investors shall avoid the following:
  • Sharing of trading credentials – login id & passwords including OTP’s.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing/ selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through WhatsApp, Telegram, YouTube, Facebook, SMS, calls, etc.
  • Trading in “Options” based on recommendations from unauthorized / unregistered investment advisors and influencers.

Awareness regarding guidelines of margin collection:
1)Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
2)Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
3)Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.
Issued in the interest of investors

Dear Investor - As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor. https://www.bseipf.com/investors_education.html

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew